Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2.
about
Targeting angiogenesis in squamous non-small cell lung cancerFour common vascular endothelial growth factor polymorphisms (-2578C>A, -460C>T, +936C>T, and +405G>C) in susceptibility to lung cancer: a meta-analysis.Circulating Ang-2 mRNA expression levels: looking ahead to a new prognostic factor for NSCLC [corrected]Angiopoietin-4 increases permeability of blood vessels and promotes lymphatic dilation.Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.Vascular endothelial growth factor gene polymorphisms and the risk of renal cell carcinoma: Evidence from eight case-control studies.Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.Association between vascular endothelial growth factor gene polymorphisms and the risk and prognosis of renal cell carcinoma: A systematic review and meta-analysisPrognostic significance of combining VEGFA, FLT1 and KDR mRNA expression in lung cancer.rs833061 and rs699947 on promoter gene of vascular endothelial growth factor (VEGF) and associated lung cancer susceptibility and survival: a meta-analysis.Expression and significance of angiopoietin-2 and cyclin D1 in laryngeal squamous cell carcinoma and the correlation with prognosis.Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas: a case-control study.Transcription factor PAX6 as a novel prognostic factor and putative tumour suppressor in non-small cell lung cancer.Ang-2 promotes lung cancer metastasis by increasing epithelial-mesenchymal transition.
P2860
Q26861341-B5016492-3A20-4D14-9C05-E977D4829F78Q35009074-27DB96A6-5C54-4FAD-B780-2FD026578440Q35108561-DE38E94F-97EC-432E-B113-41EA0F1F637FQ35632471-B0E42BDF-F589-4CAC-94E3-E4C8E1910E67Q36121903-06FA02BC-5B47-4CD1-963C-2933BB2ACB30Q37702734-40DD11D6-308A-4918-99D1-660321234469Q39117288-ECACC65B-C874-4C2E-B4AE-5ABAF50FDDD2Q39295871-896F2FF9-90E6-475E-96CE-42F5DEE06F95Q40257693-34CCE259-7033-4107-919F-DA14A6406110Q42576108-B5C8F2F7-9D24-427B-91E0-A538EDEC1B92Q42585269-78EC22F8-B846-402F-96CE-EB51EC66C446Q50908770-E017ECB6-742F-4184-96AC-02E69D605229Q52641733-7295C45F-B044-4A66-B82A-DF28C88B5798Q55348962-3DD8CE16-8C09-4AA1-86B5-EC20021F2030
P2860
Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Prognostic impacts of angiopoi ...... trongly associated with Ang-2.
@ast
Prognostic impacts of angiopoi ...... trongly associated with Ang-2.
@en
type
label
Prognostic impacts of angiopoi ...... trongly associated with Ang-2.
@ast
Prognostic impacts of angiopoi ...... trongly associated with Ang-2.
@en
prefLabel
Prognostic impacts of angiopoi ...... trongly associated with Ang-2.
@ast
Prognostic impacts of angiopoi ...... trongly associated with Ang-2.
@en
P2093
P2860
P1433
P1476
Prognostic impacts of angiopoi ...... strongly associated with Ang-2
@en
P2093
Helge Stenvold
Khalid Al-Shibli
Lill-Tove Busund
Roy M Bremnes
Sigve Andersen
Tom Donnem
P2860
P304
P356
10.1371/JOURNAL.PONE.0019773
P407
P577
2011-05-16T00:00:00Z